https://youtu.be/GyHJJGLWdjg Key highlights from Dr Lal PathLabs Ltd (LALPATHLAB) Q1 FY23 Earnings Concall Management Update: LALPATHLAB said it clocked the highest quarterly
Dr Lal PathLabs Ltd Q1 FY23 Earnings Conference Call Insights
Categories
Healthcare
Sun Pharmaceutical Industries Ltd Q1 FY23 Earnings Conference Call Insights
Key highlights from Sun Pharmaceutical Industries Ltd (SUNPHARMA) Q1 FY23 Earnings Concall Management Update: SUNPHARMA recorded the highest ever quarterly revenue in
Dr Lal PathLabs Ltd (LALPATHLAB) Q1 FY23 Earnings Concall Transcript
Dr Lal PathLabs Ltd (NSE:LALPATHLAB) Q1 FY23 Earnings Concall dated Jul. 28, 2022 Corporate Participants: Arvind Lal -- Executive Chairman Om Prakash
Gland Pharma Limited (GLAND) Q1 FY23 Earnings Concall Transcript
Gland Pharma Limited (NSE: GLAND) Q1 FY23 Earnings Concall dated Jul. 20, 2022 Corporate Participants: Sumanta Bajpayee -- Vice President, Corporate Finance and Investor
Gland Pharma Limited (GLAND) Q1 FY23 Earnings Concall Transcript
Gland Pharma Limited (NSE:GLAND) Q1 FY23 Earnings Concall dated Jul. 20, 2022 Corporate Participants: Sumanta Bajpayee -- Vice President, Corporate Finance and Investor
Lupin Ltd Q4 FY22 Earnings Conference Call Insights
https://youtu.be/KuHcJgOThAg Key highlights from Lupin Ltd (LUPIN) Q4 FY22 Earnings Concall Q&A Highlights: Pritesh Vora - Mission Street India - Analyst
Apollo Hospitals Q4 FY22 Earnings Conference Call Insights
https://youtu.be/o39b8VAmN3k Key highlights from Apollo Hospitals (APOLLOHOSP) Q4 FY22 Earnings Concall Q&A Highlights: Anubhav Aggarwal from Credit Suisse asked what impacted the
Hikal Limited (HIKAL) Q4 FY22 Earnings Concall Transcript
Hikal Limited (NSE: HIKAL) Q4 FY22 Earnings Concall dated Jun. 03, 2022 Corporate Participants: Anish Swadi -- Senior President of Animal Health and Business
Apollo Hospitals Enterprise Ltd. (APOLLOHOSP) Q4 FY22 Earnings Concall Transcript
Apollo Hospitals Enterprise Ltd. (NSE: APOLLOHOSP) Q4 FY22 Earnings Concall dated May 26, 2022 Corporate Participants: Mayank Vaswani -- Moderator Suneeta Reddy -- Managing Director Obul
Divi’s Laboratories Ltd. (DIVISLAB) Q4 FY22 Earnings Concall Transcript
Divi's Laboratories Ltd. (NSE: DIVISLAB) Q4 FY22 Earnings Concall dated May 23, 2022 Corporate Participants: Satish Choudhury -- Chief Investor Relations Officer Murali K.
Krishna Institute of Medical Sciences Ltd. (KIMS) Q4 FY22 Earnings Concall Transcript
Krishna Institute of Medical Sciences Ltd. (NSE: KIMS) Q4 FY22 Earnings Concall dated May 19, 2022 Corporate Participants: Rahul Jeewani -- IIFL Institutional Equities
Dr Lal PathLabs Ltd Q4 FY22 Earnings Conference Call Insights
https://youtu.be/XGfFd6kLFCE Key highlights from Dr Lal PathLabs Ltd (LALPATHLAB) Q4 FY22 Earnings Concall Management Update: LALPATHLAB said it saw significant shift towards
Dr Lal PathLabs Ltd (LALPATHLAB) Q4 FY22 Earnings Concall Transcript
Dr Lal PathLabs Ltd (NSE: LALPATHLAB) Q4 FY22 Earnings Concall dated May. 17, 2022 Corporate Participants: Nishid Solanki -- Arvind Lal -- Executive Chairman Om
Alkem Laboratories Ltd. (ALKEM) Q4 FY22 Earnings Concall Transcript
Alkem Laboratories Ltd. (NSE: ALKEM) Q4 FY22 Earnings Concall dated May. 13, 2022 Corporate Participants: Gagan Borana -- Investor Relations Sandeep Singh -- Managing Director Rajesh
Aarti Drugs Ltd. (AARTIDRUGS) Q4 FY22 Earnings Concall Transcript
Aarti Drugs Ltd. (NSE: AARTIDRUGS) Q4 FY22 Earnings Concall dated May. 10, 2022 Corporate Participants: Adhish Patil -- Chief Financial Officer Ankush Mahajan -- Axis Securities
Glenmark Life Sciences Limited Q4 FY22 Earnings Conference Call Summary
https://youtu.be/au71QUL41tY Key highlights from Glenmark Life Sciences Limited (GLS) Q4 FY22 Earnings Concall Q&A Highlights: Neha Manpuria of Bank of America asked
Infographic: All you need to know about Apollo Hospital Q3 results
Apollo Hospitals(NSE:APOLLOHOSP) reported its third-quarter 2022 earnings results. The hospital chain had a consolidated revenue of ₹3,656 crores with a growth of
Max Healthcare Institute Ltd Q3 FY22 Earnings Conference Call Insights
https://youtu.be/vd7Dp7Vceio Key highlights from Max Healthcare Institute Ltd (MAXHEALTH) Q3 FY22 Earnings Concall Management Update: MAXHELATH achieved the highest ever operating EBITDA
Prevest Denpro Limited Q3 FY22 Earnings Conference Call Insights
https://www.youtube.com/watch?v=ECd3N-qiOMo Key highlights from Prevest Denpro Limited (PREVEST) Q3 FY22 Earnings Concall Q&A Highlights: Pranay Jain from Dealwell Capital asked that since
Cupid Limited Q3 FY22 Earnings Conference Call Insights
https://youtu.be/bwoNY3Y0LHo Key highlights from Cupid Limited (CUPID) Q3 FY22 Earnings Concall Management Update: CUPID stated that the top and bottom line performance
Glenmark Pharmaceuticals Limited Q3 FY22 Earnings Conference Call Insights
https://www.youtube.com/watch?v=Mzpw87FqOBE Key highlights from Glenmark Pharmaceuticals Limited (GLENMARK) Q3 FY22 Earnings Concall Management Update: GLENMARK stated the India business continues to outperform